drugset / Trial / NCT02992041

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy

NCT02992041

Phase 2 Completed 69 enrolled Vivozon, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, placebo-controlled study.

Timeline

Start
2016-12-27
Primary completion
2018-04
Completion
2018-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule 900 mg Intravenous
Subject VVZ-149 Small molecule 1100 mg Intravenous

Indications

No indication recorded.